Medicines Optimisation for Respiratory Patients: The Establishment of a New Consultant Respiratory Pharmacist Role in Northern Ireland.
consultant
consultant pharmacist
medicines optimisation
optimisation
pharmacist
pharmacist services
respiratory
respiratory pharmacy
service development and implementation
Journal
Pharmacy (Basel, Switzerland)
ISSN: 2226-4787
Titre abrégé: Pharmacy (Basel)
Pays: Switzerland
ID NLM: 101678532
Informations de publication
Date de publication:
30 Oct 2021
30 Oct 2021
Historique:
received:
22
09
2021
revised:
21
10
2021
accepted:
22
10
2021
entrez:
29
11
2021
pubmed:
30
11
2021
medline:
30
11
2021
Statut:
epublish
Résumé
Medicines optimisation for those with respiratory conditions can have a significant impact on clinical outcomes and substantial efficiency gains for health care. Consultant pharmacists are experts working at the top of their specialism in four main pillars of practice, namely clinical care, leadership, education and training, and research and development. A consultant respiratory pharmacist has recently been appointed at a large Health and Social Care Trust in Northern Ireland to provide expert care and clinical leadership for the medicines optimisation agenda with regards to respiratory care in Northern Ireland. Alongside clinical practice, leadership, and service development, emphasis will be placed on monitoring and evaluating the work of the consultant respiratory pharmacist with a view to gathering the necessary evidence to support the case for further investment in such consultant pharmacist posts in the region. This short communication article outlines some of the clinical and economic factors associated with the decisions to invest in the consultant pharmacist model of care in Northern Ireland.
Identifiants
pubmed: 34842802
pii: pharmacy9040177
doi: 10.3390/pharmacy9040177
pmc: PMC8629016
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
J Health Serv Res Policy. 2008 Apr;13(2):85-91
pubmed: 18416913